Skip to Content

1,191 Results Found

  • Article
  • Open Access
1,435 Views
15 Pages

The Association Between Peripheral Arterial Disease and Long-Term Bleeding Events in Patients with Acute Myocardial Infarction

  • Soichiro Ban,
  • Kenichi Sakakura,
  • Hiroyuki Jinnouchi,
  • Yousuke Taniguchi and ,
  • Kei Yamamoto,
  • Takunori Tsukui,
  • Masashi Hatori,
  • Taku Kasahara,
  • Shun Ishibashi and
  • Hideo Fujita
  • + 7 authors+ 2 authors

Background: Peripheral arterial disease (PAD) is associated with cardiovascular events in patients with acute myocardial infarction (AMI). However, there are limited reports regarding the association between PAD and bleeding events. In this study, we...

(This article belongs to the Section Cardiovascular Medicine)
  • Review
  • Open Access
16 Citations
3,055 Views
10 Pages

Thromboembolic and Bleeding Events in Transthyretin Amyloidosis and Coagulation System Abnormalities: A Review

  • Angela Napolitano,
  • Laura De Michieli,
  • Giulio Sinigiani,
  • Tamara Berno and ,
  • Alberto Cipriani and
  • Luca Spiezia
  • + 1 author+ 0 author

20 October 2023

Transthyretin amyloidosis (ATTR) is a group of diseases caused by the deposition of insoluble fibrils derived from misfolded transthyretin, which compromises the structure and function of various organs, including the heart. Thromboembolic events and...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
5 Citations
4,121 Views
9 Pages

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors

  • Kei Kawada,
  • Tomoaki Ishida,
  • Kohei Jobu,
  • Shumpei Morisawa and ,
  • Naohisa Tamura,
  • Shouhei Sugimoto,
  • Masafumi Okazaki,
  • Saburo Yoshioka and
  • Mitsuhiko Miyamura
  • + 4 authors+ 0 author

20 October 2022

Background and Objectives: The aim of this study is to investigate the characteristics of gastrointestinal bleeding events associated with BCR-ABL tyrosine kinase inhibitor (TKI) treatment, using the reporting odds ratio (ROR) of the adverse event re...

(This article belongs to the Section Oncology)
  • Review
  • Open Access
28 Citations
3,424 Views
17 Pages

Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19

  • Cristina Tudoran,
  • Dana Emilia Velimirovici,
  • Delia Mira Berceanu-Vaduva,
  • Maria Rada and ,
  • Florica Voiţă-Mekeres and
  • Mariana Tudoran
  • + 1 author+ 0 author

The infection with the SARS-CoV-2 virus is associated with numerous systemic involvements. Besides the severe respiratory injuries and cardiovascular complications, it became obvious early on that this disease carries an increased risk of thromboembo...

(This article belongs to the Section Medical Microbiology)
  • Article
  • Open Access
1 Citations
2,390 Views
13 Pages

Major Bleeding Events in Hospitalized COVID-19 Patients: A Retrospective Observational Study

  • Andrea Poloni,
  • Giacomo Casalini,
  • Giacomo Pozza,
  • Andrea Giacomelli and ,
  • Marta Colaneri,
  • Giorgia Carrozzo,
  • Beatrice Caloni,
  • Cosmin Lucian Ciubotariu,
  • Martina Zacheo and
  • Spinello Antinori
  • + 12 authors+ 7 authors

Thromboprophylaxis/anticoagulation treatment is often required in hospitalized COVID-19 patients. We aimed to estimate the prevalence of major bleeding events in hospitalized COVID-19 patients. This was a retrospective observational study including a...

(This article belongs to the Section Infectious Disease)
  • Article
  • Open Access
2 Citations
1,890 Views
10 Pages

24 August 2022

Currently, there is no standardized consensus on anticoagulation (AC) among patients with coronavirus disease (COVID-19), which has an overwhelming bleeding risk. We aimed to compare the patterns of AC in COVID-19 patients and compare two validated r...

(This article belongs to the Section Vascular Medicine)
  • Review
  • Open Access
31 Citations
14,443 Views
12 Pages

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls

  • Anne Godier,
  • Pierre Albaladejo and
  • the French Working Group on Perioperative Haemostasis (GIHP) Group

21 July 2020

Bleeding complications are common in patients treated with antiplatelet agents (APA), but their management relies on poor evidence. Therefore, practical guidelines and guidance documents are mainly based on expert opinion. The French Working Group on...

(This article belongs to the Special Issue Platelet Counting, Morphology Assessment and Functional Studies: Pitfalls, Uncertainties, Good Practice for Clinical Usefulness)
  • Article
  • Open Access
751 Views
12 Pages

Bleeding Events During Anticoagulation After Acute Pulmonary Embolism: Real-Life Experience

  • Irina Pocienė,
  • Brigita Lebednykienė,
  • Jolita Račkauskienė,
  • Vaida Averjanovaitė and
  • Edvardas Danila

2 July 2026

Background and Objectives: Pulmonary embolism (PE) is a potentially life-threatening disease. Although anticoagulant therapy reduces the risk of recurrent PE, it increases the risk of bleeding complications. Therefore, decisions regarding treatment d...

(This article belongs to the Special Issue Chronic Respiratory Diseases: Updates on Pathophysiology, Symptoms, Diagnosis and Treatment: 2nd Edition)
  • Review
  • Open Access
3 Citations
2,771 Views
17 Pages

Definition, Incidence, Prediction, and Prevention of Bleeding Events After Transcatheter Aortic Valve Implantation

  • Iosif Xenogiannis,
  • Ioannis Lianos,
  • Grigoris V. Karamasis,
  • Charalampos Varlamos and ,
  • Fotios Kolokathis,
  • Christos Pappas,
  • Stamatia Kovra,
  • Konstantinos Tsaousidis,
  • Christos Mourmouris and
  • Andreas S. Kalogeropoulos
  • + 7 authors+ 2 authors

10 October 2025

Bleeding remains the most common complication following transcatheter aortic valve implantation (TAVI), despite a decline in its incidence over time. Periprocedural (≤30 days) major or life-threatening bleeding is reported to occur in 2.0–6....

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
3 Citations
2,430 Views
12 Pages

Incidence, Risk Factors and Mortality Associated with Major Bleeding Events in Hospitalized COVID-19 Patients

  • Marko Lucijanic,
  • Ida Tjesic-Drinkovic,
  • Nevenka Piskac Zivkovic,
  • Frane Pastrovic and ,
  • Zrinka Rob,
  • Mersiha Bacevac,
  • Martina Sedinic Lacko,
  • Eleonora Dzambas,
  • Barbara Medic and
  • Bruno Barsic
  • + 9 authors+ 4 authors

7 August 2023

Thromboprophylaxis is a mainstay of treatment of hospitalized COVID-19 patients, due to the high occurrence of thrombotic events. This increases the risk of bleeding. However, data on bleeding events and associated risk factors are scarce. Thus, we a...

(This article belongs to the Special Issue COVID-19 and Kidney Disease)
  • Article
  • Open Access
7 Citations
2,514 Views
11 Pages

Relative Importance of Heart Failure Events Compared to Stroke and Bleeding in AF Patients

  • Sandro Ninni,
  • Gilles Lemesle,
  • Thibaud Meurice,
  • Olivier Tricot and ,
  • Nicolas Lamblin and
  • Christophe Bauters
  • + 1 author+ 0 author

28 February 2021

Introduction: Incident heart failure (HF), ischemic stroke and systemic embolism (IS/SE), and major bleeding related to anticoagulation therapy are still the most frequent events occurring in patients with atrial fibrillation (AF). The aim of this st...

(This article belongs to the Special Issue New Insights into Atrial Fibrillation)
  • Article
  • Open Access
9 Citations
4,594 Views
11 Pages

Bleeding and Thrombotic Events in Hemodialysis Patients with Atrial Fibrillation on Anticoagulation and Antiplatelet Therapy: A 24-Month Cohort Study

  • Zorica M. Dimitrijevic,
  • Branka P. Mitic,
  • Danijela D. Tasic,
  • Tamara Vrecic and ,
  • Karolina Paunovic and
  • Sonja Salinger
  • + 1 author+ 0 author

27 October 2024

Background and Objectives: Patients undergoing chronic hemodialysis (HD) are predisposed to both thrombotic and bleeding complications due to the complex interplay of end-stage renal disease (ESRD), cardiovascular comorbidities, and the routine use o...

(This article belongs to the Special Issue Cardiovascular Disease and Hemodialysis)
  • Article
  • Open Access
10 Citations
6,009 Views
10 Pages

The Risk of Bleeding and Adverse Events with Clopidogrel in Elective Hip and Knee Arthroplasty Patients

  • Cheng-Ta Wu,
  • Tzu-Hsien Lien,
  • I-Ling Chen,
  • Jun-Wen Wang and ,
  • Jih-Yang Ko and
  • Mel S. Lee
  • + 1 author+ 0 author

22 March 2022

Orthopedic surgeons often face a clinical dilemma on how to manage antiplatelet therapies during the time of surgery. This retrospective study is aimed to investigate the bleeding risk and adverse events in patients who hold or keep clopidogrel durin...

(This article belongs to the Topic Orthopaedic Diseases and Innovative Intervention Strategies)
  • Article
  • Open Access
6 Citations
3,665 Views
26 Pages

Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation

  • Hans Michael Hau,
  • Markus Eckert,
  • Sven Laudi,
  • Maria Theresa Völker and ,
  • Sebastian Stehr,
  • Sebastian Rademacher,
  • Daniel Seehofer,
  • Robert Sucher,
  • Tobias Piegeler and
  • Nora Jahn
  • + 5 authors+ 0 author

12 July 2022

Objective: Due to the high prevalence and incidence of cardio- and cerebrovascular diseases among dialysis-dependent patients with end-stage renal disease (ERSD) scheduled for kidney transplantation (KT), the use of antiplatelet therapy (APT) and/or...

(This article belongs to the Special Issue Biomarkers for Cardiovascular Risk)
  • Article
  • Open Access
19 Citations
2,723 Views
10 Pages

Acquired Factor XIII Deficiency Is Common during ECMO Therapy and Associated with Major Bleeding Events and Transfusion Requirements

  • Matthias Noitz,
  • Roxane Brooks,
  • Johannes Szasz,
  • Dennis Jenner and ,
  • Carl Böck,
  • Niklas Krenner,
  • Martin W. Dünser and
  • Jens Meier
  • + 3 authors+ 0 author

18 June 2023

Background: Bleeding events are frequent complications during extracorporeal membrane oxygenation therapy (ECMO). Objective: To determine the rate of acquired factor XIII deficiency and its association with major bleeding events and transfusion requi...

(This article belongs to the Section Intensive Care)
  • Article
  • Open Access
11 Citations
3,038 Views
8 Pages

Role of Absorbable Polysaccharide Hemostatic Powder in the Prevention of Bleeding and Wound Events after Thyroid Surgery

  • Giovanni Docimo,
  • Marcello Filograna Pignatelli,
  • Sonia Ferrandes,
  • Alessandro Monaco and ,
  • Francesco Calisti,
  • Roberto Ruggiero,
  • Salvatore Tolone,
  • Francesco Saverio Lucido,
  • Luigi Brusciano and
  • Claudio Gambardella
  • + 8 authors+ 3 authors

31 August 2023

Background: Bleeding is one of the most fearsome and life-threatening complications after thyroid surgery. Several medical devices and haemostatic agents have been proposed to improve haemostasis during total and hemi-thyroidectomy. Resorbable polysa...

(This article belongs to the Section General Surgery)
  • Case Report
  • Open Access
9 Citations
6,355 Views
19 Pages

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series

  • Livija Šimičević,
  • Ana Marija Slišković,
  • Majda Vrkić Kirhmajer,
  • Lana Ganoci and ,
  • Hrvoje Holik,
  • Jozefina Palić,
  • Jure Samardžić and
  • Tamara Božina
  • + 3 authors+ 0 author

5 February 2023

Non-vitamin K antagonist oral anticoagulants’ interindividual trough concentration variability affects efficacy and safety, especially in bleeding events. Rivaroxaban is metabolised via CYP3A4/5-, CYP2J2-, and CYP-independent mechanisms and is...

(This article belongs to the Special Issue Pharmaceutical Care Services in Pharmacy Practice)
  • Article
  • Open Access
1 Citations
1,300 Views
21 Pages

Recurring Bleeding Events Requiring Red Blood Cell Transfusion After Left Atrial Appendage Closure Are Associated with Increased Mortality

  • Manuella Bogdan,
  • Balázs Polgár,
  • Előd János Zsigmond,
  • Jusztina Bencze and ,
  • Kamilla Luca Dávid,
  • Zalán Gulyás,
  • Nikolett Vigh,
  • Róbert Gábor Kiss,
  • Emese Tóth-Zsámboki and
  • Gábor Zoltán Duray
  • + 5 authors+ 0 author

30 March 2026

Background: Left atrial appendage closure (LAAC) is an established alternative to oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation who are at high risk of thromboembolic events or bleeding complications. Met...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
7 Citations
3,076 Views
13 Pages

Impact of Primary Hemostasis Disorders on Late Major Bleeding Events among Anticoagulated Atrial Fibrillation Patients Treated by TAVR

  • Laurent Dietrich,
  • Marion Kibler,
  • Kensuke Matsushita,
  • Benjamin Marchandot and ,
  • Antonin Trimaille,
  • Antje Reydel,
  • Bamba Diop,
  • Phi Dinh Truong,
  • Anh Mai Trung and
  • Olivier Morel
  • + 10 authors+ 5 authors

31 December 2021

Background: Bleeding events are among the striking complications following transcatheter aortic valve replacement (TAVR), and bleeding prediction models are crucially warranted. Several studies have highlighted that primary hemostasis disorders secon...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
16 Citations
3,304 Views
13 Pages

Ischemic and Bleeding Events Associated with Thrombocytopenia and Thrombocytosis after Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

  • Ji Woong Roh,
  • Sungmin Lim,
  • Youngdeok Hwang,
  • Kwan Yong Lee and ,
  • Eun Ho Choo,
  • Ik Jun Choi,
  • Byung-Hee Hwang,
  • Chan Joon Kim,
  • Mahn-Won Park and
  • Kiyuk Chang
  • + 16 authors+ 11 authors

21 October 2020

The early and late ischemic and bleeding clinical outcomes according to baseline platelet count after percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI) remain unclear. Overall, 10,667 patients from the Cardio...

(This article belongs to the Special Issue Acute Coronary Syndromes: Precision Treatment)
  • Article
  • Open Access
1 Citations
2,338 Views
11 Pages

Risk Factors for Bleeding Events in Japanese Patients with Advanced Lung Cancer: Data from the Rising-VTE/NEJ037 Study

  • Keita Kawakado,
  • Yukari Tsubata,
  • Takamasa Hotta,
  • Masahiro Yamasaki and ,
  • Nobuhisa Ishikawa,
  • Kazunori Fujitaka,
  • Tetsuya Kubota,
  • Kunihiko Kobayashi and
  • Takeshi Isobe
  • + 4 authors+ 0 author

10 January 2024

Despite the occurrence of various hemorrhagic events during advanced lung cancer treatment, few researchers have reported on their risk factors. Moreover, the development of cancer-related thromboembolism indicates anticoagulant use. However, adverse...

(This article belongs to the Special Issue Oncology: State-of-the-Art Research and Initiatives in Japan)
  • Article
  • Open Access
1 Citations
1,843 Views
16 Pages

LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study

  • Dong Oh Kang,
  • Cheol Ung Choi,
  • Jang Hoon Lee,
  • Young Joon Hong and ,
  • Jung-Sun Kim,
  • Han Cheol Lee,
  • Jay Young Rhew,
  • Jang Hyun Cho and
  • Weon Kim
  • + 4 authors+ 0 author

5 February 2026

Background: The widespread use of antithrombotic therapies increases bleeding risk, particularly in patients with a high bleeding risk (HBR). Although proton pump inhibitors are recommended for lowering the risk of upper gastrointestinal (UGI) bleedi...

(This article belongs to the Special Issue Current Clinical Treatments and Challenges for Cardiovascular Diseases)
  • Article
  • Open Access
5 Citations
3,494 Views
15 Pages

Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve Replacement

  • Adrien Carmona,
  • Benjamin Marchandot,
  • François Severac,
  • Marion Kibler and ,
  • Antonin Trimaille,
  • Joe Heger,
  • Marilou Peillex,
  • Kensuke Matsushita,
  • Jessica Ristorto and
  • Olivier Morel
  • + 9 authors+ 4 authors

16 July 2020

Background: The impact of coronary artery disease (CAD) and revascularization by percutaneous coronary intervention (PCI) on prognosis in patients undergoing transcatheter aortic valve replacement (TAVR) remain debated. A dismal prognosis in patients...

(This article belongs to the Section Cardiology)
  • Systematic Review
  • Open Access
17 Citations
4,038 Views
13 Pages

A Systematic Review on Bleeding Risk Scores’ Accuracy after Percutaneous Coronary Interventions in Acute and Elective Settings

  • Crischentian Brinza,
  • Alexandru Burlacu,
  • Grigore Tinica,
  • Adrian Covic and
  • Liviu Macovei

2 February 2021

Dual antiplatelet therapy (DAT) is recommended for all patients undergoing percutaneous coronary intervention (PCI), as it significantly reduces the ischemic risk at the cost of increasing the incidence of bleeding events. Several clinical predictive...

(This article belongs to the Section Medication Management)
  • Article
  • Open Access
8 Citations
2,173 Views
15 Pages

Pharmacokinetic and Pharmacogenetic Predictors of Major Bleeding Events in Patients with an Acute Coronary Syndrome and Atrial Fibrillation Receiving Combined Antithrombotic Therapy

  • Olga Baturina,
  • Maria Chashkina,
  • Denis Andreev,
  • Karin Mirzaev and ,
  • Alexandra Bykova,
  • Alexandr Suvorov,
  • Daria Yeryshova,
  • Svetlana Suchkova,
  • Dmitry Sychev and
  • Abram Syrkin
  • + 5 authors+ 0 author

12 September 2023

Objective: This study’s objective was to evaluate the effects of pharmacokinetic and pharmacogenetic factors on major bleeding in patients with ACS and non-valvular AF receiving combined antithrombotic therapy consisting of rivaroxaban, clopido...

(This article belongs to the Special Issue Precision Medicine in Coronary Artery Disease)
  • Article
  • Open Access
6 Citations
2,634 Views
10 Pages

27 June 2022

Left ventricular assist devices are a treatment option for end-stage heart failure patients. Despite advancing technologies, bleeding and thromboembolic events strongly decrease the survival and the quality of life of these patients. Little is known...

(This article belongs to the Special Issue Advances and Perspectives in Heart Failure)
  • Article
  • Open Access
20 Citations
3,728 Views
15 Pages

Prediction of Adverse Events in Stable Non-Variceal Gastrointestinal Bleeding Using Machine Learning

  • Dong-Woo Seo,
  • Hahn Yi,
  • Beomhee Park,
  • Youn-Jung Kim and ,
  • Dae Ho Jung,
  • Ilsang Woo,
  • Chang Hwan Sohn,
  • Byuk Sung Ko,
  • Namkug Kim and
  • Won Young Kim
  • + 5 authors+ 0 author

11 August 2020

Clinical risk-scoring systems are important for identifying patients with upper gastrointestinal bleeding (UGIB) who are at a high risk of hemodynamic instability. We developed an algorithm that predicts adverse events in patients with initially stab...

(This article belongs to the Special Issue AI in Medical Practice/Gastroenterology, Hepatology and Endoscopy)
  • Systematic Review
  • Open Access
138 Views
16 Pages

Perioperative Continuation Versus Discontinuation of Antiplatelet Therapy in Colorectal Surgery: A Systematic Review and Meta-Analysis of Bleeding and Thrombotic Events

  • Stefan Morarasu,
  • Bianca Codrina Morarasu,
  • Elena Diana Guzga,
  • Laurentiu Sorodoc and ,
  • Gabriel Mihail Dimofte and
  • Sorinel Lunca
  • + 1 author+ 0 author

3 November 2026

Background: Perioperative management of antiplatelet therapy in colorectal surgery requires balancing the risk of surgical bleeding against cardiovascular and cerebrovascular complications after treatment withdrawal. This meta-analysis assessed the s...

(This article belongs to the Section Hepatic and Gastroenterology Diseases)
  • Article
  • Open Access
8 Citations
3,215 Views
14 Pages

18 October 2024

Background and Objectives: Rivaroxaban is a direct-acting anticoagulant used to prevent stroke in patients with atrial fibrillation. Rivaroxaban is a substrate for P-glycoprotein, which is encoded by the ABCB1 gene. Rivaroxaban is also metabolized by...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
4 Citations
3,068 Views
17 Pages

Independent Clinical Impacts of Procedural Complexity on Ischemic and Bleeding Events in Patients with Acute Myocardial Infarction: Long-Term Clinical Study

  • Kwan Yong Lee,
  • Byung-Hee Hwang,
  • Sungmin Lim,
  • Chan Jun Kim and ,
  • Eun-Ho Choo,
  • Seung Hoon Lee,
  • Jin-Jin Kim,
  • Ik Jun Choi,
  • Gyu Chul Oh and
  • Kiyuk Chang
  • + 10 authors+ 5 authors

18 August 2022

This study aimed to investigate the relationship between a complex percutaneous coronary intervention (C-PCI) and long-term clinical outcomes in the AMI cohort. A total of 10,329 patients were categorized into the C-PCI and non-C-PCI groups. The prim...

(This article belongs to the Special Issue Coronary Artery Disease Interventions)
  • Article
  • Open Access
23 Citations
4,006 Views
17 Pages

Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes

  • Shashank Murali,
  • Sara Vogrin,
  • Samer Noaman,
  • Diem T. Dinh and ,
  • Angela L. Brennan,
  • Jeffrey Lefkovits,
  • Christopher M. Reid,
  • Nicholas Cox and
  • William Chan
  • + 4 authors+ 0 author

Bleeding severity in patients undergoing percutaneous coronary intervention (PCI), defined by the Bleeding Academic Research Consortium (BARC), portends adverse prognosis. We analysed data from 37,866 Australian patients undergoing PCI enrolled in th...

(This article belongs to the Special Issue Antithrombotic Treatment of Acute Coronary Syndrome)
  • Article
  • Open Access
2,271 Views
14 Pages

Background/Objectives: Anticoagulant therapy, particularly the use of direct oral anticoagulant agents (DOACs), is recommended for patients with nonvalvular atrial fibrillation (NVAF). This multicenter observational retrospective cohort study aimed t...

(This article belongs to the Section Clinical Pharmaceutics)
  • Article
  • Open Access
2 Citations
2,588 Views
12 Pages

Using the PEAR1 Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack

  • Yanjie Xu,
  • Dongxiao Yao,
  • Weiqi Chen,
  • Hongyi Yan and ,
  • Dexiu Zhao,
  • Lingling Jiang,
  • Yicong Wang,
  • Xingquan Zhao,
  • Liping Liu and
  • Yilong Wang
  • + 7 authors+ 2 authors

30 September 2023

In this study, we explored the relationship between the platelet endothelial aggregation receptor 1 (PEAR1) polymorphisms, platelet reactivity, and clinical outcomes in patients with minor stroke or transient ischemic attack (TIA). Randomized control...

(This article belongs to the Section Molecular and Cellular Neuroscience)
  • Article
  • Open Access
33 Citations
5,867 Views
17 Pages

Non-Vitamin K Oral Anticoagulants (NOAC) versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type

  • Ceren Eyileten,
  • Marek Postula,
  • Daniel Jakubik,
  • Aurel Toma and ,
  • Dagmara Mirowska-Guzel,
  • Giuseppe Patti,
  • Giulia Renda and
  • Jolanta M. Siller-Matula
  • + 3 authors+ 0 author

14 April 2020

Background: Our study aims to perform a meta-analysis of benefits and risks associated with the use of non-vitamin K oral anticoagulants (NOAC) versus vitamin K antagonists (VKA) in patients with a percutaneous coronary intervention (PCI) with a part...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
15 Citations
3,324 Views
14 Pages

Vascular Complications in Patients with Hepatocellular Carcinoma Treated with Sorafenib

  • Katharina Pomej,
  • Bernhard Scheiner,
  • Dabin Park,
  • David Bauer and ,
  • Lorenz Balcar,
  • Tobias Meischl,
  • Mattias Mandorfer,
  • Thomas Reiberger,
  • Christian Müller and
  • Matthias Pinter
  • + 6 authors+ 1 author

13 October 2020

VEGF(R)-targeted therapies are associated with an increased risk of thromboembolism and bleeding, which might be pronounced in patients with increased cardiovascular risk. Nevertheless, sorafenib represents an important treatment option in patients w...

(This article belongs to the Section Cancer Therapy)
  • Article
  • Open Access
1,603 Views
12 Pages

Characteristics and Treatment Patterns of Patients with Haemophilia B Receiving Recombinant Coagulation Factor IX

  • Young-Shil Park,
  • Tai Ju Hwang,
  • Sang Kyu Park,
  • Eun Jin Choi and ,
  • Jeong A Park,
  • Hee Jo Baek,
  • Chuhl Joo Lyu,
  • Jae Hee Lee,
  • Mi Kyung Kim and
  • Ki Young Yoo
  • + 12 authors+ 7 authors

26 June 2025

Introduction: In Haemophilia B, guideline-level factor IX (FIX) prophylaxis is recommended, but real-world dosing and adherence vary. Aim: To assess treatment patterns, adherence, FIX dosing, and their associations with bleeding events in Korean pati...

(This article belongs to the Section Hematology)
  • Systematic Review
  • Open Access
4 Citations
1,241 Views
23 Pages

Systematic Review and Meta-Analysis of the Frequency of Thromboembolic Events, Bleeding, and Mortality in Patients with Atrial Fibrillation and End-Stage Renal Disease Undergoing Percutaneous Left Atrial Appendage Closure

  • Juan Manuel Martínez-Arango,
  • Laura María Rojas-Echavarría,
  • Carolina García-Mejía,
  • Juan Daniel Castrillón-Spitia and
  • Luis Felipe Higuita-Gutiérrez

31 March 2026

Background: Atrial fibrillation (AF) and end-stage renal disease (ESRD) are closely related conditions that increase the risk of disability, stroke, and mortality. Anticoagulation management in patients with ESRD and AF is challenging due to the high...

(This article belongs to the Special Issue Acute Coronary Syndromes: Clinical Advances in Diagnosis and Treatment)
  • Systematic Review
  • Open Access
2 Citations
3,248 Views
13 Pages

Activated Clotting Time and Haemostatic Complications in Patients Receiving ECMO Support: A Systematic Review

  • Daniel Schwaiger,
  • Lukas Schausberger,
  • Benedikt Treml,
  • Dragana Jadzic and ,
  • Nicole Innerhofer,
  • Christoph Oberleitner,
  • Zoran Bukumirić,
  • Igor Spurnić and
  • Sasa Rajsic
  • + 4 authors+ 0 author

Background: Extracorporeal membrane oxygenation (ECMO) requires systemic anticoagulation to prevent clotting, typically using unfractionated heparin (UFH). However, anticoagulation carries a bleeding risk, necessitating monitoring. Activated clotting...

(This article belongs to the Special Issue Critical Care Update: Cardiology)
  • Systematic Review
  • Open Access
28 Citations
5,134 Views
22 Pages

Efficacy and Safety of Pathogen-Reduced Platelets Compared with Standard Apheresis Platelets: A Systematic Review of RCTs

  • Ilaria Pati,
  • Francesca Masiello,
  • Simonetta Pupella,
  • Mario Cruciani and
  • Vincenzo De Angelis

In this systematic review, we evaluate the efficacy and safety of blood components treated with pathogen reduction technologies (PRTs). We searched the Medline, Embase, Scopus, Ovid, and Cochrane Library to identify RCTs evaluating PRTs. Risk of bias...

(This article belongs to the Special Issue Pathogen Reduction of Blood Bank Components)
  • Article
  • Open Access
1,444 Views
14 Pages

A Multicenter Propensity Score-Matched Cohort Study of Preoperative Antiplatelet Therapy and Postoperative Outcomes in Elderly Surgical Patients

  • Seokyoung Song,
  • Hyungseok Seo,
  • Il Seok Kim,
  • Minsoo Kim and ,
  • Lim Youn Hee,
  • Jung Eun Kim,
  • Soo Il Choi,
  • Dong Hyuck Kim,
  • Young Hun Lee and
  • Sang Gyu Kwak
  • + 12 authors+ 7 authors

11 March 2026

Background and Objectives: Elderly patients frequently receive antiplatelet therapy, creating a clinical dilemma between bleeding risk and cardiovascular protection during surgery. We evaluated the association between preoperative antiplatelet therap...

(This article belongs to the Special Issue Perioperative Medicine: Optimizing Outcomes Through Anesthesia)
  • Article
  • Open Access
9 Citations
6,531 Views
11 Pages

Risk of Mortality among Patients with Gastrointestinal Bleeding with Early and Late Treatment with Tranexamic Acid: A Population-Based Cohort Study

  • Ke-Hsin Ting,
  • Bei-Hao Shiu,
  • Shun-Fa Yang,
  • Pei-Lun Liao and ,
  • Jing-Yang Huang,
  • Yin-Yang Chen and
  • Chao-Bin Yeh
  • + 2 authors+ 0 author

21 March 2022

Tranexamic acid (TXA) is an antifibrinolytic pharmacological agent, but its use in gastrointestinal bleeding remains contentious. Moreover, studies on the timing of TXA administration are limited. We examined whether early TXA administration reduced...

(This article belongs to the Special Issue 10th Anniversary of JCM—Recent Diagnostic and Therapeutic Advance in Gastroenterology and Hepatopancreatobiliary Medicine)
  • Article
  • Open Access
6 Citations
3,592 Views
11 Pages

Co-Administration of Amiodarone Increases Bleeding by Affecting Rivaroxaban Pharmacokinetics in Patients with Atrial Fibrillation

  • Huamin Ding,
  • Zi Wang,
  • Jia Wang,
  • Yao Yao and ,
  • Chi Zhang,
  • Houwen Lin,
  • Yong Zhou,
  • Zhichun Gu,
  • Qianzhou Lv and
  • Xiaoye Li
  • + 5 authors+ 0 author

This study aimed to investigate the impact of the drug–drug interaction between rivaroxaban and amiodarone on the clinical outcomes in patients with non-valvular atrial fibrillation (NVAF), focusing on pharmacokinetic and pharmacodynamic (PK/PD...

(This article belongs to the Section Pharmacokinetics and Pharmacodynamics)
  • Article
  • Open Access
1 Citations
2,775 Views
17 Pages

27 November 2024

Background/Objectives: The efficacy and safety of reduced-dose prasugrel (loading dose/maintenance dose: 20/3.75 mg) in preventing major adverse cardiovascular events (MACEs) among patients with acute coronary syndrome (ACS) undergoing percutaneous c...

(This article belongs to the Section Cardiovascular Medicine)
  • Article
  • Open Access
2 Citations
4,363 Views
14 Pages

Efficacy and Safety of Combination Therapy with Low-Dose Rivaroxaban in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Tommaso Bucci,
  • Francesco Del Sole,
  • Danilo Menichelli,
  • Gioacchino Galardo and ,
  • Flavio Giuseppe Biccirè,
  • Alessio Farcomeni,
  • Gregory Y. H. Lip,
  • Pasquale Pignatelli and
  • Daniele Pastori
  • + 4 authors+ 0 author

31 March 2024

Objectives: To review the evidence on the effectiveness and safety of low-dose-rivaroxaban 2.5 mg twice daily (LDR) in patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD) taking antiplatelets. Methods: We performed a sy...

(This article belongs to the Special Issue Advances in Thrombotic Disorders and Antithrombotic Treatments)
  • Article
  • Open Access
23 Citations
4,347 Views
14 Pages

Association of aPTT-Guided Anticoagulation Monitoring with Thromboembolic Events in Patients Receiving V-A ECMO Support: A Systematic Review and Meta-Analysis

  • Sasa Rajsic,
  • Robert Breitkopf,
  • Benedikt Treml,
  • Dragana Jadzic and ,
  • Christoph Oberleitner,
  • Ulvi Cenk Oezpeker,
  • Nicole Innerhofer and
  • Zoran Bukumiric
  • + 3 authors+ 0 author

30 April 2023

Background: The initiation of extracorporeal membrane oxygenation (ECMO) is associated with complex inflammatory and coagulatory processes, raising the need for systemic anticoagulation. The balance of anticoagulatory and procoagulant factors is esse...

(This article belongs to the Section Intensive Care)
  • Article
  • Open Access
6 Citations
2,602 Views
15 Pages

Adverse Events and Clinical Correlates in Asian Patients with Atrial Fibrillation and Diabetes Mellitus: A Report from Asia Pacific Heart Rhythm Society Atrial Fibrillation Registry

  • Tommaso Bucci,
  • Katarzyna Nabrdalik,
  • Alena Shantsila,
  • Giulio Francesco Romiti and ,
  • Wee-Siong Teo,
  • Hyung-Wook Park,
  • Wataru Shimizu,
  • Hung-Fat Tse,
  • Marco Proietti and
  • Asia-Pacific Heart Rhythm Society Atrial Fibrillation Registry Investigators
  • + 7 authors+ 2 authors

23 February 2024

Aims. To evaluate the adverse events (and its clinical correlates) in a large prospective cohort of Asian patients with atrial fibrillation (AF) and diabetes mellitus (DM). Material and Methods. We recruited patients with atrial fibrillation (AF) fro...

(This article belongs to the Section Cardiology)
  • Article
  • Open Access
5 Citations
3,386 Views
13 Pages

Catheter-Directed Thrombolysis in the Management of Thrombotic Peripheral Artery Occlusions—Acute and Mid-Term Clinical Outcomes

  • Ulrich Beschorner,
  • Tanja Boehme,
  • Elias Noory,
  • Roaa Bollenbacher and ,
  • Jonas Salm,
  • Kambis Mashayekhi,
  • Dirk Westermann and
  • Thomas Zeller
  • + 3 authors+ 0 author

26 September 2024

Objectives: To evaluate the safety and efficacy of catheter-directed thrombolysis (CDT) with the recombinant tissue plasminogen activator (rt-PA) in all patients with symptomatic peripheral artery disease in real world practice. Methods: Consecutive...

(This article belongs to the Section Vascular Medicine)
  • Feature Paper
  • Article
  • Open Access
1 Citations
1,765 Views
18 Pages

Clinical and Economic Impact of a First Major Bleeding Event in Non-Anticoagulated Patients in Spain: A 3-Year Retrospective Observational Cohort Study

  • Carlos Escobar,
  • Beatriz Palacios,
  • Miriam Villarreal,
  • Martín Gutiérrez and ,
  • Margarita Capel,
  • Ignacio Hernández,
  • María García,
  • Laura Lledó and
  • Juan F. Arenillas
  • + 4 authors+ 0 author

19 February 2025

Objective: To analyze clinical characteristics of non-anticoagulated subjects with major bleeding, and to determine the incidence of adverse events, healthcare resource utilization (HCRU) and associated costs following a major bleeding event. Methods...

(This article belongs to the Section Cardiovascular Medicine)
  • Article
  • Open Access
6 Citations
2,819 Views
16 Pages

15 August 2023

We aimed to characterize the performance and safety of percutaneous coronary intervention (PCI) in complex, high-risk indicated procedure (CHIP) and high-bleeding-risk (HBR) patients at a 4-year follow up. We included all consecutive patients who und...

(This article belongs to the Special Issue Interventional Cardiology: Current Challenges in Clinical Practice)
  • Article
  • Open Access
3 Citations
2,903 Views
16 Pages

Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study

  • Carlos Escobar,
  • Beatriz Palacios,
  • Miriam Villarreal,
  • Martín Gutiérrez and ,
  • Margarita Capel,
  • Unai Aranda,
  • Ignacio Hernández,
  • María García,
  • Laura Lledó and
  • Juan F. Arenillas
  • + 5 authors+ 0 author

21 July 2024

Aims: Our aims were to describe the clinical characteristics, adverse clinical events, healthcare resource utilization (HCRU) and costs of patients with major bleeding during direct Factor Xa inhibitor (FXai) use. Methods: This is a retrospective coh...

(This article belongs to the Section Hematology)

of 24